MYBL2 and neuroblastoma: Last, our study defined for the first time through a cross-species integrative transcriptomics approach putative master regulators for MYCN-driven neuroblastoma tumor development and revealed FOXM1 and the DREAM complex members MYBL2 and E2F8 as top-scoring candidates.